These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29355746)

  • 1. Bone remodelling in vitro: Where are we headed?: -A review on the current understanding of physiological bone remodelling and inflammation and the strategies for testing biomaterials in vitro.
    Kohli N; Ho S; Brown SJ; Sawadkar P; Sharma V; Snow M; García-Gareta E
    Bone; 2018 May; 110():38-46. PubMed ID: 29355746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development, physiology, and cell activity of bone].
    de Baat P; Heijboer MP; de Baat C
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-culture systems of osteoblasts and osteoclasts: Simulating in vitro bone remodeling in regenerative approaches.
    Borciani G; Montalbano G; Baldini N; Cerqueni G; Vitale-Brovarone C; Ciapetti G
    Acta Biomater; 2020 May; 108():22-45. PubMed ID: 32251782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD169
    Batoon L; Millard SM; Wullschleger ME; Preda C; Wu AC; Kaur S; Tseng HW; Hume DA; Levesque JP; Raggatt LJ; Pettit AR
    Biomaterials; 2019 Mar; 196():51-66. PubMed ID: 29107337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of normal bone remodelling.
    Katsimbri P
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28786518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models.
    Ehnert S; Rinderknecht H; Aspera-Werz RH; Häussling V; Nussler AK
    Arch Toxicol; 2020 Dec; 94(12):3937-3958. PubMed ID: 32910238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of osteoclasts in bone tissue engineering.
    Detsch R; Boccaccini AR
    J Tissue Eng Regen Med; 2015 Oct; 9(10):1133-49. PubMed ID: 24478169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying osteogenic cell degradation of silk biomaterials.
    Sengupta S; Park SH; Seok GE; Patel A; Numata K; Lu CL; Kaplan DL
    Biomacromolecules; 2010 Dec; 11(12):3592-9. PubMed ID: 21105641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based resorption assays for bone graft substitutes.
    Zhang Z; Egaña JT; Reckhenrich AK; Schenck TL; Lohmeyer JA; Schantz JT; Machens HG; Schilling AF
    Acta Biomater; 2012 Jan; 8(1):13-9. PubMed ID: 21971416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of bone turnover.
    Väänänen HK
    Ann Med; 1993 Aug; 25(4):353-9. PubMed ID: 8217101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the regulation of bone remodelling at the cellular level.
    Kular J; Tickner J; Chim SM; Xu J
    Clin Biochem; 2012 Aug; 45(12):863-73. PubMed ID: 22465238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular mechanism behind bone remodelling: a review.
    Proff P; Römer P
    Clin Oral Investig; 2009 Dec; 13(4):355-62. PubMed ID: 19319579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cells around bone biomaterials: Osteoclasts or multi-nucleated giant cells?
    Miron RJ; Zohdi H; Fujioka-Kobayashi M; Bosshardt DD
    Acta Biomater; 2016 Dec; 46():15-28. PubMed ID: 27667014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts.
    Sims NA; Vrahnas C
    Arch Biochem Biophys; 2014 Nov; 561():22-8. PubMed ID: 24875146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hafnium (IV) oxide obtained by atomic layer deposition (ALD) technology promotes early osteogenesis via activation of Runx2-OPN-mir21A axis while inhibits osteoclasts activity.
    Seweryn A; Alicka M; Fal A; Kornicka-Garbowska K; Lawniczak-Jablonska K; Ozga M; Kuzmiuk P; Godlewski M; Marycz K
    J Nanobiotechnology; 2020 Sep; 18(1):132. PubMed ID: 32933533
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Owen R; Reilly GC
    Front Bioeng Biotechnol; 2018; 6():134. PubMed ID: 30364287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.